CEBPA and non-small cell lung carcinoma: In this research, we performed a bioinformatics analysis to detect shared molecular mechanism-based biomarkers (CEBPA, TGFBR2, EZH2, JUNB, JUN, FOS, PLAU, COL1A1) between NSCLC and AMI, validating their correlation and identifying candidate drugs targeting hub genes.